Professional
Added to YB: 2024-05-29
Pitch date: 2024-03-31
BAYN.DE [neutral]
Bayer Aktiengesellschaft
+60.65%
current return
Author Info
No bio for this author
Company Info
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments.
Market Cap
EUR 45.3B
Pitch Price
EUR 28.37
Price Target
N/A
Dividend
0.24%
EV/EBITDA
9.43
P/E
-228.86
EV/Sales
1.70
Sector
Pharmaceuticals
Category
turnaround
Harris Associates Global Strategy Portfolio Holding: Bayer Aktiengesellschaft
BAYN.DE: Recent RoundUp jury verdict bigger than avg but likely reduced on appeal; since won 2 cases. Capital markets day lacked major updates as litigation strategy kept private, no mid-term targets, and break-up deferred for balance sheet. Support mgmt's profitability & cash focus + bureaucracy cuts. 2023 results & 2024 guide in line.
Read full article (1 min)